Limited Use Note(s)

Government of Ontario Logo
FILGRASTIM480mcg/1.6mL 1.6mL Vial
Reason For Use CodeClinical Criteria
447Pre-Stem Cell Transplant Mobilization: For Peripheral Blood Progenitor Cell (PBPC) collection for peripheral stem cell transplant as treatment for malignant disease. Approval for Neupogen 300mcg and 480mcg vial format only.
LU Authorization Period: 14 days
NOTE: Reimbursement is limited to the duration required per the treatment protocol and to prescriptions written by an oncologist or hematologist.
500For pediatric patients (less than 18 years age) who are unable to achieve the appropriate dose of granulocyte colony-stimulating factor with the formulary listed formats of pre-filled syringes. Approval for Neupogen 300mcg vial format only.
LU Authorization Period: 1 year
501For patients who are unable to use available formats of Grastofil due to a documented latex allergy. Approval for Neupogen 300mcg and 480mcg vial format only.
LU Authorization Period: Indefinite.